PSA Stratification for Predicting Advanced Prostate Cancer Events in Men Approaching Age-Limits for Recommended Screening.

Paul J RiviereLeah N DeshlerKylie M MorganEdmund M QiaoAlex K BryantBrent S Rose

Published in: The Journal of urology (2024)

In men aged 70 to 75 deciding whether to cease PSA testing with borderline-elevated PSA values, the risk of developing metastatic or fatal prostate cancer is quantifiable and relatively low. Risk assessment in this setting must account for the higher incidence of prostate cancer in Black men.

Keyphrases

prostate cancer
radical prostatectomy
risk assessment
middle aged
squamous cell carcinoma
small cell lung cancer
risk factors
human health